Cathie Wood’s ARK sells CareDx stock, buys Natera and Kratos
At a glance
- $CDNA today+2.92%last $78.56
- 52-week range13.5% below high$15.15 – $90.87
- Coverage3 this week6 in 30 days · 2.1× its usual pace
- Sector scannerCalmHealth Care
What it means
- What to watch: Policy moves the whole healthcare aisle; trial data moves one company. Knowing which kind of story this is helps.
- How the stocks are trading: $CDNA +2.92%, $NTRA -14.59% in the latest session.
- Timing: It arrived overnight — the change beside it belongs to a session that had already packed up and gone home. Market holidays are not detected.
Where the stock stands
$CDNA last traded at $78.56, +2.92% on the session. That puts it 14% shy of its 52-week high of $90.87 and 419% clear of its low of $15.15 — in the upper part of the range. Over the year it has ranged 500% from low to high: a very wide band; big swings are routine for this one, not news. $NTRA last changed hands at $310.67, -14.59% on the session, 29% below its 52-week high of $437.41 and 72% above its low of $181.00 — around the middle of the range. Over the year it has ranged 142% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices.
How much coverage it is getting
In the last 30 days Wook has filed 6 stories about these names — 3 of them this week. At its 30-day pace you would expect about 1 a week, so this week is running well ahead of normal; the press has found a reason to keep writing. Across those stories 0 read bullish, 6 neutral and 0 bearish. This one reads neutral, so it sits squarely with the crowd. 6 of the 6 (100%) came from Investing.com itself, so the count says as much about how often Investing.com hits publish as about how much attention there is — the other outlets are the better gauge. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
What to watch next
The $CDNA page has the full chart, the filings and the valuation model behind every figure here. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. And Wook AI, up top, will happily do the math — how far $CDNA sits from its high, or how this week's coverage stacks up.
Discussion
No one has weighed in yet. Start the discussion on this story.